SMA 50 společnosti AC Immune SA
Jaká je hodnota metriky SMA 50 společnosti AC Immune SA?
Hodnota metriky SMA 50 společnosti AC Immune SA je $3 -14.06%
Jaká je definice metriky SMA 50?
SMA 50 je průměrná cena akcií z posledních 50 dnů vypočítaná jako nevážený průměr předchozích 50 závěrečných cen.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností AC Immune SA
Čemu se věnuje společnost AC Immune SA?
ac immune is a clinical-stage swiss-based biopharmaceutical company, listed on nasdaq, which aims to become a global leader in precision medicine for neurodegenerative diseases. the company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. ac immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as alzheimer’s disease (ad). the company’s pipeline features nine therapeutic and three diagnostic product candidates – with five product candidates currently in clinical trials. the most advanced of these is crenezumab, a humanized anti-amyloid-β monoclonal igg4 antibody that targets monomeric and aggregated forms of amyloid-β, with highest affinity for neurotoxic oligomers. crenezumab is currently in two phase 3 clinical studies for ad, under a global program conducted by the collabor
Firmy s metrikou sma 50 podobnou společnosti AC Immune SA
- Hodnota metriky SMA 50 společnosti THL Credit je $3 +3.46%
- Hodnota metriky SMA 50 společnosti Impex Ferro Tech je ₨3 +8.27%
- Hodnota metriky SMA 50 společnosti Weiqiao Textile je HKD$3 +0.07%
- Hodnota metriky SMA 50 společnosti Dare Bioscience Inc je $3 -7.03%
- Hodnota metriky SMA 50 společnosti Red Lion Hotels je $3 +0.00%
- Hodnota metriky SMA 50 společnosti APN Convenience Retail REIT je AUD$3 +0.00%
- Hodnota metriky SMA 50 společnosti AC Immune SA je $3 -14.06%
- Hodnota metriky SMA 50 společnosti Haitong Securities Co je HKD$3 +4.61%
- Hodnota metriky SMA 50 společnosti Avalon GloboCare je $3 -564.58%
- Hodnota metriky SMA 50 společnosti Vistagen Therapeutics je $3 -10.95%
- Hodnota metriky SMA 50 společnosti Gran Colombia Gold je CAD$3 -12.38%
- Hodnota metriky SMA 50 společnosti Avalon GloboCare je $3 -564.58%
- Hodnota metriky SMA 50 společnosti Alps Industries je ₨3 +4.66%